Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Intensive Treatment with Atorvastatin Inhibits Rho Kinase Activity in Patients with Atherosclerosis

Intensive Treatment with Atorvastatin Inhibits Rho Kinase Activity in Patients with Atherosclerosis. Circulation. 2008; 118(18 Suppl 2):S553.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.